| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 06/02/2005 | WO2005048739A1 Vanadium ion-containing agent for improving sugar, lipid and/or nitrogen metabolisc errors |
| 06/02/2005 | WO2005048709A1 Use of panthenol in teat dip/spray preparations |
| 06/02/2005 | WO2005041889A3 Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants |
| 06/02/2005 | WO2004087098A3 Preserved ophthalmic compositions |
| 06/02/2005 | US20050119598 High citrate dialysate and uses thereof |
| 06/02/2005 | US20050119299 Ophthalmic solutions containing tetrazole derivatives |
| 06/02/2005 | US20050119223 Injectable solution containing a shark-derived chondroitin sulfate iron colloid |
| 06/02/2005 | US20050119170 Therapy for anaphylactic shock |
| 06/02/2005 | US20050118565 Systems and methods for assessing neuronal degeneration |
| 06/02/2005 | US20050118281 Substantially non-colloidal solution made by combining ingredients comprising (a) water; (b) a source of free silver ions; and (c) a substantially non-toxic, substantially thiol-free, substantially water-soluble complexing agent. |
| 06/02/2005 | US20050118280 Micronized wood preservative formulations |
| 06/02/2005 | US20050118279 Mineral, nutritional, cosmetic, pharmaceutical, and agricultural compositions and methods for producing the same |
| 06/02/2005 | US20050118278 Pharmaceutical or cosmetic composition, preventing or reducing itch and local reaction from stings of insects |
| 06/02/2005 | US20050118250 Lipid carrier compositions with enhanced blood stability |
| 06/02/2005 | US20050118187 Combinations and methods for treating neoplasms |
| 06/02/2005 | US20050118150 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 06/02/2005 | US20050118117 Methods for identifying risk of melanoma and treatments thereof |
| 06/02/2005 | CA2546019A1 Therapeutic peg solution concentrate |
| 06/01/2005 | EP1534314A1 A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction |
| 06/01/2005 | EP1534308A2 Peptides with growth inhibitory action |
| 06/01/2005 | EP1534305A2 Treating cartilage / bone conditions with water-soluble strontium salts |
| 06/01/2005 | EP1534304A1 An analgesic agent for newborn or fetal subjects |
| 06/01/2005 | EP1119321B1 Patient temperature regulation method and apparatus |
| 06/01/2005 | EP0873110B1 Improved hemostatic composition for treating gingival area |
| 06/01/2005 | CN1621044A Composition for preventing and treating arthritis, formulation containing said composition, its preparation process and usage |
| 06/01/2005 | CN1203866C Soluble nutritious powder with multiple elements, vitamins and amino acids and its preparation method |
| 06/01/2005 | CN1203865C Injection for enhancing immunity and its preparing method |
| 06/01/2005 | CN1203777C Universal detoxicant |
| 05/31/2005 | US6900197 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 05/31/2005 | US6900180 Mixture of folic acid, vitamin b6 and b12 with carbohydrates, fats and proteins; infant formula; sleep disorders |
| 05/31/2005 | US6900174 Comprises mineral (chromium and/or vanadium) bound by glycoprotein matrix produced by yeast (Saccharomyces cervisiae); for inhibiting absorption of dietary starch; for obesity and other carbohydrate limited dieting |
| 05/31/2005 | US6899903 Antiinflammatory agents; respiratory system disorders; spraying mixture of herbs, colloidal silver, grapefruit seed extract and preservative |
| 05/31/2005 | US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/31/2005 | US6899868 Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/31/2005 | US6899700 Therapeutic agent delivery tampon |
| 05/26/2005 | WO2005046746A2 Medical implants and fibrosis-inducing agents |
| 05/26/2005 | WO2005046738A2 Virucidal activities of cetylpyridinium chloride |
| 05/26/2005 | WO2005046708A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 05/26/2005 | WO2005046702A1 Method of inhibiting alveolar resorption and peridental membrane loss and composition for internal use to be used therein |
| 05/26/2005 | WO2005046360A2 Carbohydate and electrolyte replacement composition |
| 05/26/2005 | WO2005030028A3 Methods for detecting presence of cellular constituents |
| 05/26/2005 | US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 05/26/2005 | US20050112214 Method for reducing acne for improving skin tone |
| 05/26/2005 | US20050112213 Compositions of improved sucralfate and sucrose octasulfate and method of use |
| 05/26/2005 | US20050112212 Herbal formulation |
| 05/26/2005 | US20050112210 Age-related macular degeneration; include vitamins, minerals, and antioxidants such as vitamins A, C, E, zinc, lutein and zeaxanthin |
| 05/26/2005 | US20050112208 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation |
| 05/26/2005 | US20050112179 Method to reduce stool odor of companion animals |
| 05/26/2005 | US20050112114 Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 05/26/2005 | US20050112066 Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity |
| 05/26/2005 | US20050112021 Reduction of Contaminants In Blood and Blood Products Using Photosensitizers and Peak Wavelengths of Light |
| 05/26/2005 | US20050109981 Neutralize biological pathogens; sterilization of medical equipment; food processing equipment; mixture of bleaching activator, base and water |
| 05/26/2005 | CA2545606A1 Carbohydrate and electrolyte replacement composition |
| 05/26/2005 | CA2545117A1 Virucidal activities of a combination of cetylpyridinium chloride and citric acid |
| 05/26/2005 | CA2545062A1 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 05/26/2005 | CA2536041A1 Medical implants and fibrosis-inducing agents |
| 05/25/2005 | EP1532982A2 Pharmaceutical ointment for the complete therapy of dermatologic diseases |
| 05/25/2005 | EP1531869A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immunoconjugates and chemotherapeutic agents |
| 05/25/2005 | EP1531843A1 Method for treating cervical cancer |
| 05/25/2005 | EP1531837A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 05/25/2005 | EP1531836A2 Polypeptide cleavage process |
| 05/25/2005 | EP1531827A2 Copper lowering treatment of inflammatory and fibrotic diseases |
| 05/25/2005 | EP1411908B1 Nitrogen oxide generating compositions for the treatment of subungual infections |
| 05/25/2005 | EP1210131A4 Herb medicine composition to be spread on sanitary napkin for female |
| 05/25/2005 | CN1620314A Gas micro-liposome compound |
| 05/25/2005 | CN1620280A 感染控制系统 Infection Control System |
| 05/25/2005 | CN1620257A Matrix-forming composition containing pectin |
| 05/25/2005 | CN1202855C Traditional Chinese medicine for deafness and tinnitus and its preparation method |
| 05/25/2005 | CN1202849C Oral liquid for nephrosis |
| 05/25/2005 | CN1202845C Medicine for treating prostatosis and its prepn |
| 05/25/2005 | CN1202733C Food and process for manufacturing same |
| 05/24/2005 | US6897349 Silver-containing compositions, devices and methods for making |
| 05/24/2005 | US6896909 Formulations containing iron ores for the topical treatment of bioenergetic and electromagnetic disorders |
| 05/24/2005 | US6896902 Effervescent solid composition of matter |
| 05/24/2005 | CA2315408C A double capsule for the administration of active principles in multiple therapies |
| 05/24/2005 | CA2211177C Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates |
| 05/19/2005 | WO2005044287A1 Disinfecting composition and methods of making and using same |
| 05/19/2005 | WO2005044286A1 Pharmaceutical for prevention and/or treatment of cerebral infarction |
| 05/19/2005 | WO2005025501A3 Co-administration of polysaccharide with a chemotherapeutic agent for the treatment of cancer |
| 05/19/2005 | WO2005020879A3 Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| 05/19/2005 | WO2005000211A3 Method for treating diseases using hsp90-inhibiting agents in combination with platinum coordination complexes |
| 05/19/2005 | WO2004064719A3 Synergistic compositions and methods for potentiating anti-oxidative activity |
| 05/19/2005 | US20050107380 Administering substance P receptor antagonist selected from the group consisting of L 742694, L 758298, and LY 303241, a non-toxic magnesium compound and a pharmaceutically acceptable vehicle |
| 05/19/2005 | US20050107346 Synergistic treatment, better effects on solid tumours; with a mixture of a platinum anticancer agents and a taxane, with ionizing radiation therapy |
| 05/19/2005 | US20050107291 Compositions and methods for treating or preventing diseases of body passageways |
| 05/19/2005 | US20050107287 Administering cisplatin; drug delivery; reduced dosage to prevent release into systemic circulation; platinum containing compound entrapped in salt crystals; andone or more lipids |
| 05/19/2005 | US20050106270 Chemical treatment of in vivo tissue to alter charge and net charge density characteristics |
| 05/19/2005 | US20050106267 Zeolite molecular sieves for the removal of toxins |
| 05/19/2005 | US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate) |
| 05/19/2005 | US20050106263 comprises Green Tea leaf extract, Polyphenols, Epigallocatechin Gallate (EGCG) Vitamin E, Folic Acid, Copper (as Amino Acid Chelate), B12, Zinc (as Oxide), Calcium Pantothenate, Niacin, Biotin, Riboflavin and Thiamine |
| 05/19/2005 | US20050106262 colon tumour, gastric tumour, mammary tumour, ovarian tumour, prostate tumour, and renal tumour |
| 05/19/2005 | US20050106261 Rapid reduction of the alcohol level in blood; by use of multivalent transition metal ions and their complexes, and NAD+ which enhance the oxidation reaction |
| 05/19/2005 | US20050106244 Tablets, granules formed by compression |
| 05/19/2005 | US20050106121 Antimicrobial composites, films, labelstocks, and labels |
| 05/19/2005 | CA2549570A1 Medicament for prophylactic and/or therapeutic treamtent of cerebral infarction |
| 05/19/2005 | CA2545157A1 Disinfecting composition and methods of making and using same |
| 05/18/2005 | EP1530969A1 Combination chemotherapy |
| 05/18/2005 | EP1530720A2 Breast cancer eradication program |
| 05/18/2005 | EP1326502B1 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate |
| 05/18/2005 | CN1617873A Aluminium and hexa methylene tetramine composite and application thereof |